Signal
Roche and Genentech halt development of muscle growth antibody for rare diseases
Evidence first: scan the strongest sources, then decide whether to go deeper.
Published 2026-03-20 15:52 UTCUpdated 2026-03-20 18:17 UTC
rss
clinical_trialsdrug_developmentrare_diseasessafety_signals
Source links open
Source links and full evidence are open here. Archive history, compare-over-time, alerts, exports, API, integrations, and workflow are paid.
No card needed for the free brief.
Evidence trail (top sources)
top sources (2 domains)domains are deduped. counts indicate coverage, not truth.2 top sources shown
limited source diversity in top sources
Overview
Roche has stopped development of its experimental SMA drug emugrobart after it failed to consistently improve muscle growth and motor function in a key study.
Entities
RocheGenentechemugrobart
Score total
0.98
Momentum 24h
2
Posts
2
Origins
2
Source types
1
Duplicate ratio
0%
Why now
- Recent trial results showed lack of consistent efficacy in muscle growth and motor function.
- Decisions to halt development affect patients currently enrolled in studies and future treatment options.
- Signals potential reevaluation of similar antibody therapies in related indications.
Why it matters
- Highlights challenges in developing effective muscle growth therapies for rare diseases.
- Impacts ongoing clinical trials and future R&D strategies for muscle-related conditions.
- Raises questions about antibody approaches in muscle preservation, including obesity trials.
LLM analysis
Topic mix: lowPromo risk: lowSource quality: medium
Recurring claims
- The antibody candidate failed to boost muscle growth in rare genetic diseases.
How sources frame it
- Roche: neutral
- Genentech: neutral
All evidence
All evidence
Genentech is halting development of an antibody for two rare genetic diseases after the candidate failed to boost muscle growth, raising questions about whether the molecule can...
Fierce Biotech · fiercebiotech.com · 2026-03-20 18:17 UTC
Roche stops work on experimental SMA drug
BioPharma Dive · biopharmadive.com · 2026-03-20 15:52 UTC
Show filters & breakdown
Posts loaded: 0Publishers: 2Origin domains: 2Duplicates: -
Showing 2 / 0
Top publishers (this list)
- Fierce Biotech (1)
- BioPharma Dive (1)
Top origin domains (this list)
- fiercebiotech.com (1)
- biopharmadive.com (1)